Sign in

CIK 0001935979 · Large accelerated filer

Biohaven Ltd.

Sign in to watch
Ticker
BHVN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Virgin Islands, British
Entity type
operating
Phone
203-404-0410
Business address
215 CHURCH STREET, NEW HAVEN, CT, 06510
Former names
Biohaven Research Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Options (Right to Buy) −387 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Options (Right to Buy) −34,612 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Options (Right to Buy) −1,199 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Options (Right to Buy) −48,801 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Options (Right to Buy) −43,750 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Options (Right to Buy) −98,458 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Options (Right to Buy) −1,542 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Options (Right to Buy) −9,620 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Options (Right to Buy) −90,380 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Option (Right to Buy) −20,000 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Option (Right to Buy) −25,000 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Option (Right to Buy) −50,000 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Option (Right to Buy) −37,500 0
2022-10-03 Coric Vlad Chief Executive Officer Option exercise · Stock Option (Right to Buy) −125,000 0
2022-10-03 Coric Vlad Chief Executive Officer Grant or award · Stock Option (Right to Buy) +950,000 950,000

Page 18 of 18 · 355 trades